by meng
• 🧠 The best Alzheimer's Disease Paper published yesterday, ranked by impact factor • 🏥 Clinical insights and how institutions are responding • 💡 Therapeutic innovations and emerging treatment targets • 🎯 Practical takeaways for physicians, neurologists, and medical researchers Get journal's impact factors at : https://www.journalmetrics.org Find clinical trials easily : https://www.clinicaltrialsfind.com Find NIH grants trend: https://www.gotgrant.com
Language
🇺🇲
Publishing Since
5/26/2025
See how your podcast performs across key metrics
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
June 21, 2026
June 21, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare
June 20, 2026
June 20, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare
June 19, 2026
June 19, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Clinical Evaluation of the Revised Biological and Clinical Staging Criteria for Alzheimer Disease in China. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
• 🧠 The best Alzheimer's Disease Paper published yesterday, ranked by impact factor • 🏥 Clinical insights and how institutions are responding • 💡 Therapeutic innovations and emerging treatment targets • 🎯 Practical takeaways for physicians, neurologists, and medical researchers
Get journal's impact factors at : https://www.journalmetrics.org Find clinical trials easily : https://www.clinicaltrialsfind.com Find NIH grants trend: https://www.gotgrant.com
This podcast updates daily.
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
No, this podcast does not typically feature guests.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.